搜尋結果
4 天前 · – Limited Number of Warrants Convertible at $20 Per Share Remain – Company Has Paid Off All Bridge Notes in Full Boston (May 7, 2024)—Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a clinical-stage pharmaceutical company dedicated to developing personalized cancer treatments, today announced that its capital structure has been simplified.
2 天前 · other attributes to warrant further development or to achieve regulatory approval, the risk that results observed in prior studies of the Company’s product candidates, including preclinical studies and clinical trials, will not be observed in ongoing or future the ...
1 天前 · Each whole Warrant entitles the holder thereof to purchase one Common Share for $0.05 expiring two (2) years from the date of the closing of the Offering. The Warrants will include an acceleration provision whereby if the Company’s Common Shares trade at a price greater than $0.10 for a period of 20 consecutive trading days, Marksmen may accelerate the expiry of the Warrants.
2024年4月9日 · 04月09日 08:38 新浪網. 【#南部戰區位南海海域開展演訓活動#】#堅決維護南海地區和平穩定# 南部戰區新聞發言人田軍里空軍大校表示，4月7日至8日，中國人民解放軍南部戰區組織海空兵力位南海海域，開展戰機巡邏警戒、海空聯合突擊、艦艇編隊戰備巡航等演訓 ...
2024年4月29日 · 勞工處下月實施新修訂的《預防工作時中暑指引》，將暑熱警告和天文台「極端酷熱天氣」特別提示連結，以避免警告在取消後短時間內重發的情況。. 新安排亦為僱主提供休息時間賦予彈性，包括可因應工作需要，安排僱員在每小時不同時段休息，而休息時間 ...
1 天前 · A Good Start for Year 2024 HONG KONG, May 10, 2024 /PRNewswire/ — Goodbaby International Holdings Limited (“Goodbaby International” or the “Company”; HKEX stock code: 1086, together with its subsidiaries, the “Group“), a leading global parenting products company, has announced its unaudited revenue performance for the three months ended 31 March 2024 (the “Period”), with ...
3 天前 · ABI-6250, a small molecule orally-bioavailable HDV entry inhibitor. First Quarter 2024 Financial Results. Cash, cash equivalents and marketable securities were $113.0 million as of March 31, 2024, compared to $130.2 million as of December 31, 2023. Assembly Bio’s cash position is projected to fund operations into the second half of 2025.
